By Marie Rosenthal
LAS VEGAS—Everyone from Congress to patients is making a fuss about the cost of specialty drugs, but it’s the employers that might actually do something about the issue.
“I’m constantly reminding folks in the industry that the real payors are the employers. Roughly 160 million commercial lives come through employers,” said Jorge A. Font, MPH, at the 2017 Specialty Pharmacy Summit.